New interpretable machine-learning method for single-cell data reveals correlates of clinical response to cancer immunotherapy.
Détails
Télécharger: 34950900_BIB_4AF9E6EB0D95.pdf (4996.09 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_4AF9E6EB0D95
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
New interpretable machine-learning method for single-cell data reveals correlates of clinical response to cancer immunotherapy.
Périodique
Patterns
ISSN
2666-3899 (Electronic)
ISSN-L
2666-3899
Statut éditorial
Publié
Date de publication
10/12/2021
Peer-reviewed
Oui
Volume
2
Numéro
12
Pages
100372
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Publication Status: epublish
Résumé
We introduce a new method for single-cell cytometry studies, FAUST, which performs unbiased cell population discovery and annotation. FAUST processes experimental data on a per-sample basis and returns biologically interpretable cell phenotypes, making it well suited for the analysis of complex datasets. We provide simulation studies that compare FAUST with existing methodology, exemplifying its strength. We apply FAUST to data from a Merkel cell carcinoma anti-PD-1 trial and discover pre-treatment effector memory T cell correlates of outcome co-expressing PD-1, HLA-DR, and CD28. Using FAUST, we then validate these correlates in cryopreserved peripheral blood mononuclear cell samples from the same study, as well as an independent CyTOF dataset from a published metastatic melanoma trial. Finally, we show how FAUST's phenotypes can be used to perform cross-study data integration in the presence of diverse staining panels. Together, these results establish FAUST as a powerful new approach for unbiased discovery in single-cell cytometry.
Mots-clé
algorithms, bioinformatics, cancer, immunology, single-cell, statistics & probability
Pubmed
Web of science
Open Access
Oui
Création de la notice
04/01/2022 8:39
Dernière modification de la notice
23/11/2022 7:10